TOP2A aberrations as predictive and prognostic marker in high-risk breast cancer patients: A randomized DBCG Trial (DBCG89D)

Ann Knoop, H. Knudsen, E. Balslev, B.B. Rasmussen, Jens Overgaard, M. During, K.V. Nielsen, J.T. Jørgensen, Henning Mouridsen, Bent Ejlertsen

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2006
StatusUdgivet - 2006
Begivenhed42nd ASCO Annual Meeting - Georgia World Congress Center, Atlanta, Georgia, USA
Varighed: 2. jun. 20066. jun. 2006
Konferencens nummer: 42

Konference

Konference42nd ASCO Annual Meeting
Nummer42
LandUSA
ByGeorgia World Congress Center, Atlanta, Georgia
Periode02/06/200606/06/2006

Citationsformater